← Health care and life sciences companies

    Aardvark Therapeutics: company profile, size and contacts

    aardvarktherapeutics.comActiveFor profit

    Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders.

    Employees
    11-50
    Founded
    2017
    Total raised
    $129M
    Monthly visits
    1,780

    Company facts

    Website
    aardvarktherapeutics.com
    Location
    Greater San Diego Area, West Coast, Western US
    Employees
    11-50
    Founded
    2017 (9 years ago)
    Categories
    Biotechnology, Health Care, Therapeutics
    Company type
    For profit
    Listing
    Private
    Industry code (NAICS)
    6211 Offices of physicians; 3254 Pharmaceutical and medicine manufacturing
    Industry code (SIC)
    8000 Health services; 2834 Pharmaceutical preparations

    Founders

    • Andreas NiethammerFounder · Aardvark Therapeutics
    • Tien LeeFounder · Aardvark Therapeutics

    Aardvark Therapeutics was founded in 2017 by Andreas Niethammer, Tien Lee.

    Funding

    Total raised
    $129M
    Funding rounds
    3
    Latest round
    Series C, 2024-05
    Investors
    18
    Lead investors
    4

    Web and app presence

    Monthly website visits
    1,780
    Global traffic rank
    #4,860,711

    How Aardvark Therapeutics compares

    • Size: Aardvark Therapeutics has more employees than 15% of the 1251 health care and life sciences companies in our directory that report it.
    • Age: Aardvark Therapeutics is older than 11% of the 1166 health care and life sciences companies in our directory that report it.
    • Web traffic: Aardvark Therapeutics gets more monthly website visits than 47% of the 1233 health care and life sciences companies in our directory that report it.

    1282 health care and life sciences companies are in the directory, 519 of them in the same 11-50 employee range and 28 based in Greater San Diego Area.

    Growth outlook

    • Trend: Growing
    • Direction: Growing
    • Confidence: High

    Aardvark Therapeutics raised $85 million in a Series C funding round. The company is also preparing for a $200 million IPO.

    What Aardvark Therapeutics says about itself

    “Aardvark Therapeutics is a clinical-stage biopharmaceutical company developing novel, small-molecule therapies designed to inhibit hunger and treat metabolic” aardvarktherapeutics.com

    Aardvark Therapeutics in short

    Founded in 2017, Aardvark Therapeutics works in biotechnology, health care and therapeutics from Greater San Diego Area and has 11-50 employees. It has raised $129 million over 3 rounds and its website drew about 1,780 visits in the latest month measured.

    Frequently asked questions

    What does Aardvark Therapeutics do?
    Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders.
    When was Aardvark Therapeutics founded?
    Aardvark Therapeutics was founded in 2017, so it is about 9 years old.
    How many employees does Aardvark Therapeutics have?
    Crunchbase lists Aardvark Therapeutics in the 11-50 employee range.
    Where is Aardvark Therapeutics based?
    Aardvark Therapeutics is listed under Greater San Diego Area, West Coast, Western US.
    Has Aardvark Therapeutics raised funding?
    Crunchbase records $129M raised across 3 funding rounds, most recently series c in 2024-05.
    How do I find email addresses at Aardvark Therapeutics?
    Search the domain aardvarktherapeutics.com with the Inbound Labs Domain Search or Email Finder to see verified contacts and departments. Individual addresses are shown after you sign up.

    Similar companies

    More in Health care and life sciences companies.

    Data sources: company facts, funding and leadership from Crunchbase; website traffic estimates from Semrush (latest month); company website, checked 2026-11-10; industry codes from the US NAICS and SIC lists; comparisons calculated from the profiles in this directory.